Navigation und Service

Springe direkt zu:

Service menu

Search

Projects

TRICE

Training on Investigation and Control of Epidemics
Strengthening Expertise to Examine Outbreaks of Haemorrhagic Fever and Antibiotic-Resistant Organisms

Short description

Compared to other regions in the world, the African continent is faced with a particularly high number of infectious diseases. These include acute fevers of unknown origin as well as anti-infective-resistant pathogens that have barely been examined to date. This demonstrates a significant shortcoming, as illustrated by the recent Ebola outbreak in West Africa. TRICE is focused on recording infections in the context of outpatient or inpatient care, assessing how resistant the detected pathogens are to anti-infectives, developing diagnostics for haemorrhagic fevers (such as Ebola), and establishing prevention strategies.

These knowledge gaps are to be filled by introducing targeted training components. These include laboratory training sessions on bacterial pathogen diagnostics, blood culture diagnostics, resistance testing, fevers of unknown origin, and training modules on the epidemiology of infectious disease, surveillance in hospitals as well as detecting and managing outbreaks (within and outside hospitals). These training sessions are conducted on the ground and adapted to local conditions.

The project is being carried out in collaboration with the BMBF funded German-African health research network ANDEMIA and the GHPP Project ARGOS.

Aims of the project

  • Supporting prevention and intervention activities relating to transmitted hospital infections and pathogen-specific outbreaks among the population, as well as with regard to the targeted use of anti-infectives.
  • Strengthening expertise in laboratory diagnostics, the development of local surveillance systems in hospitals, and the investigation and combating of outbreaks

Infos

Partner countries:

Côte d'Ivoire, Burkina Faso, Democratic Republic of the Congo, South African Republic

Partner institutions:

  • Côte d'Ivoire: University Teaching Hospital, University of Bouaké (CHU Bouaké), Central Laboratory of Animal Pathology (LANADA)
  • Burkina Faso: Centre Muraz (CM)
  • Democratic Republic of the Congo: National Institute for Biomedical Research (INRB), University Hospital, University Kinshasa (UH Kin)
  • South African Republic: National Institute for Communicable Diseases (NICD), University of Pretoria (UP)
  • Germany: Institute of Tropical Medicine and International Health, Charité – Universitätsmedizin Berlin (ITMIH/Charité)